The Pharmagellan Guide To Biotech Forecasting And Valuation
Download The Pharmagellan Guide To Biotech Forecasting And Valuation full books in PDF, epub, and Kindle. Read online free The Pharmagellan Guide To Biotech Forecasting And Valuation ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
The Pharmagellan Guide to Biotech Forecasting and Valuation
Author | : Frank S. David,Seth Robey,Andrew Matthews |
Publsiher | : Pharmagellan, LLC |
Total Pages | : 138 |
Release | : 2017-01-06 |
Genre | : Business & Economics |
ISBN | : 099840750X |
Download The Pharmagellan Guide to Biotech Forecasting and Valuation Book in PDF, Epub and Kindle
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.
The Pharmagellan Guide to Analyzing Biotech Clinical Trials
Author | : Frank David |
Publsiher | : Unknown |
Total Pages | : 135 |
Release | : 2022-01-10 |
Genre | : Electronic Book |
ISBN | : 0998407526 |
Download The Pharmagellan Guide to Analyzing Biotech Clinical Trials Book in PDF, Epub and Kindle
A comprehensive primer to help non-experts evaluate clinical studies of new therapies. If you work in or around biotech, you're supposed to understand clinical trial results. But what if you're not an expert in study design or biostatistics? You may feel out of your comfort zone when faced with a journal article, press release, or investor presentation. Inside this book: -- Structured roadmap for assessing the main components of a planned orcompleted biotech trial.-- Clear explanations of the most common concepts and terms in biotechclinical studies, illustrated with over 100 real-world examples.-- Deep dives on essential topics like p values, sample size calculations, andKaplan-Meier curves, written in plain English for non-statisticians.-- Pointers for interpreting positive and negative study results, understandingcommon figures and tables, and identifying red flags in press releases.If you're a biotech executive, investor, advisor, or entrepreneur--or aspire to be one--this handbook will give you the foundation you need to analyze planned and completed clinical trials with more confidence."Hugely helpful. I wish I'd had a book like this earlier in my career." - SIR MENEPANGALOS, Executive VP, Biopharmaceuticals R&D, AstraZeneca"A terrific primer for non-experts looking to better evaluate new therapies." -DAPHNE ZOHAR, Founder and CEO, PureTech Health"Crisp and clear. Wise advice on when to rely on clinical data and when to beskeptical." - MICHAEL ROSENBLATT, Senior Partner, Flagship Pioneering"A source of much-needed illumination." - DAN LEPANTO, Senior ManagingDirector, M&A, SVB Leerink
Forecasting for the Pharmaceutical Industry
Author | : Arthur G. Cook |
Publsiher | : CRC Press |
Total Pages | : 234 |
Release | : 2016-03-03 |
Genre | : Business & Economics |
ISBN | : 9781317134107 |
Download Forecasting for the Pharmaceutical Industry Book in PDF, Epub and Kindle
Forecasting for the Pharmaceutical Industry is a definitive guide for forecasters as well as the multitude of decision makers and executives who rely on forecasts in their decision making. In virtually every decision, a pharmaceutical executive considers some type of forecast. This process of predicting the future is crucial to many aspects of the company - from next month's production schedule, to market estimates for drugs in the next decade. The pharmaceutical forecaster needs to strike a delicate balance between over-engineering the forecast - including rafts of data and complex ’black box’ equations that few stakeholders understand and even fewer buy into - and an overly simplistic approach that relies too heavily on anecdotal information and opinion. Arthur G. Cook's highly pragmatic guide explains the basis of a successful balanced forecast for products in development as well as currently marketed products. The author explores the pharmaceutical forecasting process; the varied tools and methods for new product and in-market forecasting; how they can be used to communicate market dynamics to the various stakeholders; and the strengths and weaknesses of different forecast approaches. The text is liberally illustrated with tables, diagrams and examples. The final extended case study provides the reader with an opportunity to test out their knowledge. The second edition has been updated throughout and includes a brand new chapter focusing on specialized topics such as forecasting for orphan drugs and biosimilars.
Biotechnology Valuation
Author | : Karl Keegan |
Publsiher | : John Wiley & Sons |
Total Pages | : 228 |
Release | : 2008-12-31 |
Genre | : Business & Economics |
ISBN | : 9780470511787 |
Download Biotechnology Valuation Book in PDF, Epub and Kindle
The first book to provide a simple and practical means of valuing biotech companies The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them Praise for Biotechnology Valuation "Keegan states that the valuation of Biotech companies is as much an art as a science. This brief but comprehensive review of the skills and knowledge required, not of just the financial market and sentiment, but also of the technical attributes of a company and the drug development and regulatory hurdles that must be overcome, highlights the importance of the breadth of understanding required. Biotech investing is not for the timid, but it can bring substantial returns. Keegan's book, punctuated with his personal experience and opinions, is a good place to start." —Chris Blackwell, Chief Executive, Vectura Group plc "A user-friendly, yet thorough discussion of a notoriously difficult topic. Dr Keegan's book is a fine resource for both business types and academicians." —Steve Winokur, Managing Director, CanaccordAdams "A highly readable and comprehensive explanation of the technical and commercial parameters that influence biotechnology companies at all stages of development, providing clear context for selection from the toolkit of valuation methodologies the author recommends to assess company and product performance, or ascribe value." —Dr L.M. Allan, Director, Bioscience Enterprise Programme, University of Cambridge "A fabulous approach to a difficult topic." —Deirdre Y. Gillespie, MD, President & CEO, La Jolla Pharmaceutical Company
Single Use Technology in Biopharmaceutical Manufacture
Author | : Regine Eibl,Dieter Eibl |
Publsiher | : John Wiley & Sons |
Total Pages | : 672 |
Release | : 2019-07-24 |
Genre | : Medical |
ISBN | : 9781119477778 |
Download Single Use Technology in Biopharmaceutical Manufacture Book in PDF, Epub and Kindle
Authoritative guide to the principles, characteristics, engineering aspects, economics, and applications of disposables in the manufacture of biopharmaceuticals The revised and updated second edition of Single-Use Technology in Biopharmaceutical Manufacture offers a comprehensive examination of the most-commonly used disposables in the manufacture of biopharmaceuticals. The authors—noted experts on the topic—provide the essential information on the principles, characteristics, engineering aspects, economics, and applications. This authoritative guide contains the basic knowledge and information about disposable equipment. The author also discusses biopharmaceuticals’ applications through the lens of case studies that clearly illustrate the role of manufacturing, quality assurance, and environmental influences. This updated second edition revises existing information with recent developments that have taken place since the first edition was published. The book also presents the latest advances in the field of single-use technology and explores topics including applying single-use devices for microorganisms, human mesenchymal stem cells, and T-cells. This important book: • Contains an updated and end-to-end view of the development and manufacturing of single-use biologics • Helps in the identification of appropriate disposables and relevant vendors • Offers illustrative case studies that examine manufacturing, quality assurance, and environmental influences • Includes updated coverage on cross-functional/transversal dependencies, significant improvements made by suppliers, and the successful application of the single-use technologies Written for biopharmaceutical manufacturers, process developers, and biological and chemical engineers, Single-Use Technology in Biopharmaceutical Manufacture, 2nd Edition provides the information needed for professionals to come to an easier decision for or against disposable alternatives and to choose the appropriate system.
Emerging Protein Biotherapeutics
Author | : Iqbal S. Grewal |
Publsiher | : CRC Press |
Total Pages | : 372 |
Release | : 2009-06-26 |
Genre | : Medical |
ISBN | : 9781420063219 |
Download Emerging Protein Biotherapeutics Book in PDF, Epub and Kindle
Given the speed at which antibody therapy is becoming readily accepted, a comprehensive industry guide is sorely needed. Written by leading international authorities, this book maintains an overall emphasis on various therapeutic approaches and applications and provides critical discussions on the most significant areas of research in biologics. It focuses on the applications of protein biologics in autoimmunity and inflammation, hematological malignancies, and solid tumors. Each chapter clearly presents the most informative and contemporary account of its subject available, making this an unrivaled reference source beneficial to those in both academia and biotechnology industries.
The Biotech Investor s Bible
Author | : George Wolff |
Publsiher | : John Wiley & Sons |
Total Pages | : 374 |
Release | : 2001-06-13 |
Genre | : Business & Economics |
ISBN | : 0471412791 |
Download The Biotech Investor s Bible Book in PDF, Epub and Kindle
"The Biotech Investor's Bible" ist der maßgebliche Leitfaden für die Geldanlage in die zunehmend beliebteren, aber außerordentlich schwankungsanfälligen Biotechnologiewerte. Dieses einzigartige Buch erklärt die Grundlagen von Genetik, Patenten und Therapien und zeigt dem Anleger, wie er Biotechnologieunternehmen, deren Spitzentechnologie und neuesten Produkte bewertet. "The Biotech Investor's Bible" bietet eine interessante Zusammenfassung der relativ kurzen Geschichte dieses Industriezweiges und vermittelt einen umfassenden Überblick über verschiedene Branchenbereiche. Technologie und Wissenschaft des Biotechnologiemarktes werden zusammen mit detaillierten Investmentstrategien ausführlich erläutert. Autor George Wolff ist ein erfahrener Experte auf diesem Gebiet. "The Biotech Investor's Bible" ist eine unverzichtbare Lektüre für aktuelle und künftige Biotech-Anleger.
Mapping the Markets
Author | : Deborah Owen,Robin Griffiths |
Publsiher | : John Wiley & Sons |
Total Pages | : 148 |
Release | : 2006-10-01 |
Genre | : Business & Economics |
ISBN | : 1576602389 |
Download Mapping the Markets Book in PDF, Epub and Kindle
The global financial markets turn over billions of dollars daily. An array of different instruments is available to trade in these markets, ranging from simple stocks and shares to exotic creatures such as butterfly spreads. Participation at any level involves taking a view as to which way the market in question will move. There are essentially only two methods for analysing the future direction of the markets in equities, currencies, interest rates or commodities: one involves fundamental analysis, the other technical analysis. The two camps of investment analysts are separated by a wide gulf of distrust and suspicion. This book seeks to bridge the gap between the two disciplines and show how you can benefit from both, highlighting: • The tools you can use for mapping the markets—to understand what causes shifts in the trend and underlying forces that affect the economy and therefore the financial markets • The long-term cyclical drivers—how economic change is triggered by technological change, and the technological changes that will drive the markets in the future • Downward phases of the cycle—and the factors that cause them • The markets and sectors that will prosper in the future. As the world of investment gets ever more complicated and faster, Mapping the Markets will provide an invaluable route to improving your chances of investment success and avoiding investment distress, whether you are a long-term investor or a short-term trader.